Cargando…
Integrative rare disease biomedical profile based network supporting drug repurposing or repositioning, a case study of glioblastoma
BACKGROUND: Glioblastoma (GBM) is the most aggressive and common malignant primary brain tumor; however, treatment remains a significant challenge. This study aims to identify drug repurposing or repositioning candidates for GBM by developing an integrative rare disease profile network containing he...
Autores principales: | McGowan, Erin, Sanjak, Jaleal, Mathé, Ewy A., Zhu, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519087/ https://www.ncbi.nlm.nih.gov/pubmed/37749605 http://dx.doi.org/10.1186/s13023-023-02876-2 |
Ejemplares similares
-
Integrative Rare Disease Biomedical Profile based Network Supporting Drug Repurposing, a case study of Glioblastoma
por: McGowan, Erin, et al.
Publicado: (2023) -
Clustering rare diseases within an ontology-enriched knowledge graph
por: Sanjak, Jaleal, et al.
Publicado: (2023) -
Precision information extraction for rare disease epidemiology at scale
por: Kariampuzha, William Z., et al.
Publicado: (2023) -
Correction: Precision information extraction for rare disease epidemiology at scale
por: Kariampuzha, William Z., et al.
Publicado: (2023) -
Exploring NCATS In-House Biomedical Data for Evidence-based Drug Repurposing
por: Liu, Fang, et al.
Publicado: (2023)